Researchers have found that medicinal cannabis could be a promising treatment for adults with autism spectrum disorder (ASD), according to a study published in Therapeutic Advances in Psychopharmacology. The study investigated the effects of medicinal cannabis on 74 autistic participants, with an average age of 33, and found improvements in their health-related quality of life, anxiety, depression and sleep after one-, three- and six-month intervals.
The study’s findings indicate that using cannabis can improve health-related quality of life, anxiety, depression and sleep without the need to modify the core traits of autism. Simon Erridge, head of research and access at Sapphire Medical Clinics, who led the study, emphasized that additional research is required to fully comprehend the possible benefits of medical cannabis for adults with ASD.
Medicinal cannabis was well-tolerated by more than 80% of the participants.
The researchers noted that medical cannabis could address the limitations of medications currently prescribed to people, such as benzodiazepines and antipsychotics, which have their own range of side effects.
Past research has also explored the impact of medicinal cannabis on autistic children, adolescents and adults. Two studies, one from 2018 and another from 2019, recorded improvements in the quality of life of autistic individuals, especially in terms of depression, restlessness and anger.
While more research is necessary, the recent study provides hope for those seeking support and treatment to navigate a neurotypical world that does not always understand or accommodate their unique needs.
To stay updated with top startup news and investments, sign up for Benzinga's Startup Investing & Equity Crowdfunding Newsletter
The challenges of living with ASD can be especially difficult for some autistic adults. Social interactions may prove to be a struggle, and they may experience fixations on routines as well as sensitivities to light or sound. These symptoms, which are commonly associated with autistic children, can continue into adulthood and make independent living challenging. For those people, cannabis could be a game-changer. While cannabis continues to struggle, there are a number of startups still popping up that haven't given up hope. For example, startups like Chow420 are looking to increase transparency and access to CBD and cannabis-based products, while building out the infrastructure so others can expand using their platform.
It's no secret cannabis has seen a general lack of traction in the markets. Difficult regulatory concerns coupled with stiff competition can often mean hard times for companies. For example,
See more on startup investing from Benzinga:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.